BioMimetic Therapeutics Inc.

BioMimetic Therapeutics Receives First Orthopedic Marketing Approval for Augment™ Bone Graft.
Blood Weekly; 11/19/2009; 1136 words; BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced...indications in Canada (see also BioMimetic Therapeutics, Inc.). "After rigorous pre-clinical...clinical evaluation of the product, BioMimetic is now ready to introduce this...

BioMimetic Therapeutics Reports 2009 Third Quarter Earnings Results.(Financial report)
Biotech Week; 11/18/2009; 785 words; BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) reported...rate securities (see also BioMimetic Therapeutics, Inc.). Comparatively, the...Graft in Canada. Keywords: BioMimetic Therapeutics, Inc., Health, Biotechnology...

BioMimetic Therapeutics Releases 2009 3Q Earnings.
Health & Beauty Close-Up; 11/10/2009; 1691 words; BioMimetic Therapeutics, Inc. has reported its financial results as of and for the three...technology," said Dr. Samuel E. Lynch, president and CEO of BioMimetic Therapeutics. "The injectable formulation will allow delivery of the...

BIOMIMETIC THERAPEUTICS REPORTS MULTIPLE TRANSACTIONS BY CEO LYNCH (Tennessee)
US Fed News Service, Including US State News; 11/7/2009; 315 words; WASHINGTON, Nov. 7 -- BioMimetic Therapeutics, Inc. (BMTI), Franklin, Tenn., has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial...

BioMimetic Therapeutics Gets Orthopedic Marketing OK for Augment Bone Graft.
Health & Beauty Close-Up; 11/6/2009; 538 words; BioMimetic Therapeutics, Inc. announced that it has received...clinical evaluation of the product, BioMimetic is now ready to introduce this novel...Canada within 30 days. BioMimetic Therapeutics is a biotech company utilizing recombinant...